PDCD1 and neoplasm: For example, high microsatellite instability (MSI-H), programmed death-1 (PD-1), programmed cell death ligand 1 (PD-L1), tumor mutational burden, and mismatch repair deficient (dMMR) have been widely used in clinic as predictive biomarkers for ICIs.